Are changes in Ki-67 labeling indices during neoadjuvant chemotherapy for advanced ovarian cancer associated with survival?
Changes of the Ki-67 index during NACT are associated with progression-free survival. If confirmed in prospective trials, an increasing Ki-67 index during preoperative treatment may serve as an indicator for resistance to chemotherapy.
Levodopa normalized the increased cortico-motoneuron excitability in PD patients before, during, and after fatiguing exercise.